3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
6
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
3
Neoplasm Metastasis
2
Carcinoma, Hepatocellular
2
Urinary Bladder Neoplasms
1
Sarcoma
1
Retinoblastoma
1
Prostatic Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Gastric Cancer Metastatic to Liver
1
Carcinoma, Renal Cell
1
Carcinoma, Ductal, Breast
1
Breast Neoplasms, Male
1
Advanced Biliary Tract Cancer
1
Interventions
Sorafenib
9
Radiofrequency Ablation
7
Oxaliplatin
7
Fluorouracil
6
Doxorubicin
6
Neoadjuvant Therapy
5
toripalimab
4
lenvatinib
4
Injections
4
Chemotherapy, Adjuvant
4
Bevacizumab
4
sintilimab
3
pembrolizumab
3
Ultrasonography
3
Thalidomide
3
Leucovorin
3
Irinotecan
3
Cisplatin
3
tislelizumab
2
durvalumab
2
camrelizumab
2
anlotinib
2
Walking Speed
2
Standard of Care
2
Radiosurgery
2
Oncolytic Virotherapy
2
Metformin
2
Liver Transplantation
2
Laparoscopy
2
Immunohistochemistry
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Liver Neoplasms
×
Cryosurgery
×
Clear all
NCT03223142
2017-07-21
SMTATS
Shanghai Zhongshan Hospital
Phase NA
Unknown
100 enrolled